Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
4/20/2007
 
First Published:
4/1/1998
1.
Phase III Randomized Study of BAY 12-9566 Versus Gemcitabine in Patients With Advanced or Metastatic Adenocarcinoma of the Pancreas (Summary Last Modified 11/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
CAN-NCIC-PA1
BAYER-STR-CO2, PA1
Last Modified:
11/1/1999
 
First Published:
6/1/1998
2.
Phase III Randomized Study of BAY 12-9566 Versus Placebo in Patients with Small Cell Lung Cancer in Complete or Partial Remission (Summary Last Modified 11/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
BAYER-12-9566/D97-027
CWRU-BAYR-1597, IMPACT-100009, NCI-V98-1411
Last Modified:
11/1/1999
 
First Published:
7/1/1998
3.
Phase III Randomized Study of BAY 12-9566 versus Placebo in Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer (Summary Last Modified 11/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
BAYER-12-9566/D97-028
BAYER-12-9566, RPCI-DS-9803
Last Modified:
2/1/2005
4.
Phase I Study of BAY-12-9566 in Patients With Advanced Cancer (Summary Last Modified 03/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
Pharmaceutical / Industry
CAN-NCIC-IND107
BAYER-12-9566/STRCPI, IND107
Last Modified:
4/20/2007
 
First Published:
9/1/1998
5.
Phase I Study of BAY 12-9566 and Fluorouracil or Doxorubicin in Patients with Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
CAN-NCIC-IND113
BAYER-STR-C01, IND113
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute